pCONUS 2 and pCONUS 2-HPC for the treatment of wide-necked intracranial aneurysms: Periprocedural, 6-month, and early 2-year follow-up outcomes.

James YeomansA Sastry

Published in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2021)

pCONUS 2 and pCONUS 2-HPC have excellent short and medium-term safety profiles and clinical outcomes with no procedure-related mortality or morbidity and good occlusion rates at 6-month follow-up. The use of pCONUS 2-HPC with single antiplatelet therapy is feasible and did not cause any complications.

Keyphrases

antiplatelet therapy
percutaneous coronary intervention
acute coronary syndrome
risk factors
preterm infants
cardiovascular events
minimally invasive
type diabetes
metabolic syndrome
atrial fibrillation
skeletal muscle
adipose tissue
drug induced
preterm birth